York Gwill bought ANRO
February 6, 2024 · Form 4 insider transaction
York Gwill bought 23,917 shares of Alto Neuroscience, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
23,917
Price
N/A
Total value
N/A
InsiderYork Gwill
RoleDirector
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateFebruary 6, 2024
Filing dateFebruary 7, 2024
Shares owned after23,917
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each share of Series A Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.2241 for 1 basis and had no expiration date.